Arndt Vogel, Full Professor at Princess Margaret Cancer Centre, shared on X:
“Off the press!
Beyond rejection risk: Identifying ideal candidates for pretransplant immune checkpoint inhibitors for HCC
Liver Transplantation
ICI before TX is feasible, but we need to better define timing and candidates.”
Title: Beyond rejection risk: Identifying ideal candidates for pretransplant immune checkpoint inhibitors for HCC
Authors: Laia Aceituno, Grainne M. O’Kane, Woo Jin Choi, Parissa Tarbizian, Roxana Bucur, Nadia Rukavina, Anudari Zorigtbaatar, Beatriz Mínguez, Arndt Vogel, Gonzalo Sapisochin.
Other articles about GI Oncology on OncoDaily.